2025-06-03-Jefferies-瑞普利金公司（RGEN）_即将到来的价格上涨_对订单的潜在影响_7页_102kb

Repligen Corporation (RGEN) is expected to increase prices by 2.5% effective July 1, 2025, due to rising costs, including raw materials. Current prices will be honored for orders with November 30, 2025 delivery dates, potentially encouraging pre-emptive orders, especially from the equipment side (about 25% of revenue). Jefferies Equity Research maintains a HOLD rating with a $160 price target (+35% from current $118.57), citing risks like competition, M&A integration, and pricing pressures in its valuation. The company focuses on high-value consumables for biologics manufacturing, with a market cap of $6.7B.